NYSE:OCX
OncoCyte Corp Stock News
$2.48
+0.0400 (+1.64%)
At Close: Apr 26, 2024
Oncocyte Provides Corporate Update And Reports First Quarter 2020 Financial Results
08:05pm, Tuesday, 12'th May 2020
Announced Final Medicare LCD from Palmetto for DetermaRx™, Potentially Establishing Medicare Coverage for up to 70% of Eligible Early-Stage NSCLC Patients Signed First.
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 11)
Acceleron Pharma Inc (NASDAQ...
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Lineage Cell Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Update
12:00am, Thursday, 07'th May 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medic
Oncocyte to Report First Quarter 2020 Financial Results on Tuesday, May 12
12:00pm, Tuesday, 05'th May 2020
IRVINE, Calif., May 05, 2020 -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision.
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
Oncocyte Announces Final Medicare LCD from Palmetto for DetermaRx™
06:21pm, Thursday, 30'th Apr 2020
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
Oncocyte Announces $10.7 Million Registered Offering
12:00pm, Friday, 24'th Apr 2020
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
Edited Transcript of OCX earnings conference call or presentation 25-Mar-20 8:30pm GMT
02:55am, Thursday, 16'th Apr 2020
Q4 2019 OncoCyte Corp Earnings Call
Read This Before Selling OncoCyte Corporation (NYSEMKT:OCX) Shares
07:35pm, Tuesday, 07'th Apr 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
Medical Services Outlook Bright Amid Coronavirus Crisis
01:00pm, Tuesday, 07'th Apr 2020
Medical Services Outlook Bright Amid Coronavirus Crisis
Medical Services Outlook Bright Amid Coronavirus Crisis
01:00pm, Tuesday, 07'th Apr 2020
Despite the coronavirus-led worldwide sales disruption, medical services is one of the few sectors witnessing industry-wide growth right now.
Oncocyte to Participate at 19th Annual Needham Virtual Healthcare Conference
12:00pm, Tuesday, 07'th Apr 2020
Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, today announced th
ONCOCYTE PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS
08:05pm, Wednesday, 25'th Mar 2020
Initiated Commercial Launch of DetermaRxTM in U.S. Completed Acquisition of Insight Genetics Initiated Research Use Launch of DetermaIOTM After Completion of CLIA Validation.
